Table of Contents:

1 Report Prologue
2 Executive Summary
3 Market Introduction
3.1 Scope of Study
3.2 Research Objective
3.3 List of Assumptions
3.4 Market Structure
4 Research Methodology
4.1 Research Process
4.2 Primary Research
4.3 Secondary Research
4.4 Market Size Estimation
4.5 Forecast Model
5 Market Dynamics
5.1 Introduction
5.2 Drivers
5.2.1 Growing prevalence of traumatic brain injuries
5.2.2 Ongoing product development & commercialization will boost the adoption of hydrocephalus shunts in the market
5.2.3 Favorable reimbursement policies provide favorable background for the market growth
5.2.4 Increasing prevalence of neurovascular diseases such as brain aneurysm, Arteriovenous Malformations (AVMs), and others, are likely to propel the hydrocephalus market
5.3 Restraints
5.3.1 High procedural cost of ICP monitoring devices
5.3.2 Shortage of trained professionals
5.4 Opportunities
5.4.1 Increase in awareness of intraoperative neurophysiological monitoring (IONM)
5.4.2 Increasing use of endovascular embolization for the treatment of brain aneurysm
5.4.3 Technological advancements in over the wire micro guide catheters
5.5 Challenges
5.5.1 Rising partnership among competitors leading to rivalry
5.6 Changing economic conditions globally
6 Market Factor Analysis
6.1 Porter's Five Forces Model
6.1.1 Bargaining Power of Suppliers
6.1.2 Bargaining Power of Buyers
6.1.3 Threat of New Entrants
6.1.4 Threat of Substitutes
6.1.5 Intense Rivalry
6.2 Value chain analysis
6.2.1 R&D
6.2.2 Manufacturing
6.2.3 Distribution & Sales
6.2.4 Post-Sales Monitoring
6.3 Investment Opportunities
7 Global Hydrocephalus Market, By Type
7.1 Introduction
7.1.1 Congenital hydrocephalus
7.1.2 Acquired hydrocephalus
7.1.3 Normal-pressure hydrocephalus
7.1.4 Ex-vacuo hydrocephalus
8 Global Hydrocephalus Market, By Diagnosis
8.1 Introduction
8.1.1 CT scan - head
8.1.2 MRI
8.1.3 Head Ultrasound
9 Global Hydrocephalus Market, By Treatment
9.1 Introduction
9.1.1 Surgery - Shunt Insertion
9.1.2 Ventriculostomy
9.1.3 Medication
10 Global Hydrocephalus Market, By End User
10.1 Introduction
10.1.1 Hospitals & Clinics
10.1.2 Diagnostic Centres
10.1.3 Academic Institutions and Research Organizations
11 Global Hydrocephalus Market, By Region
11.1 Introduction
11.2 Americas
11.2.1 North America
11.2.1.1 US
11.2.1.2 Canada
11.2.2 South America
11.3 Europe
11.4 Western Europe
11.4.1 Germany
11.4.2 UK
11.4.3 France
11.4.4 Spain
11.4.5 Italy
11.4.6 Rest of Western Europe
11.4.7 Eastern Europe
11.5 Asia-Pacific
11.5.1 China
11.5.2 Japan
11.5.3 India
11.5.4 Australia
11.5.5 South Korea
11.5.6 Rest of Asia-Pacific
11.6 Middle East & Africa
11.6.1 Middle East
11.6.2 Africa
12 Competitive Landscape
12.1 Competitive Scenario
12.1.1 Introduction
12.2 Company Market Share Analysis
12.2.1 Introduction
12.3 Key Developments
13 Company Profiles
13.1 DePuy Synthes
13.1.1 Company Overview
13.1.2 Financial Overview
13.1.3 Products Offering
13.1.4 Key Developments
13.1.5 SWOT Analysis
13.1.6 Key Strategy
13.2 Boston Neurosciences
13.2.1 Company Overview
13.2.2 Financial Overview
13.2.3 Products Offering
13.2.4 Key Developments
13.2.5 SWOT Analysis
13.2.6 Key Strategy
13.3 Medtronic Plc
13.3.1 Company Overview
13.3.2 Financial Overview
13.3.3 Products Offering
13.3.4 Key Developments
13.3.5 SWOT Analysis
13.3.6 Key Strategy
13.4 Integra LifeSciences Corporation
13.4.1 Company Overview
13.4.2 Financial Overview
13.4.3 Products Offering
13.4.4 Key Developments
13.4.5 SWOT Analysis
13.4.6 Key Strategy
13.5 Spiegelberg GmbH & Co. KG
13.5.1 Company Overview
13.5.2 Financial Overview
13.5.3 Products Offering
13.5.4 Key Developments
13.5.5 SWOT Analysis
13.5.6 Key Strategy
13.6 RAUMEDIC Inc.
13.6.1 Company Overview
13.6.2 Financial Overview
13.6.3 Products Offering
13.6.4 Key Developments
13.6.5 SWOT Analysis
13.6.6 Key Strategy
13.7 Sophysa SA
13.7.1 Company Overview
13.7.2 Financial Overview
13.7.3 Products Offering
13.7.4 Key Developments
13.7.5 SWOT Analysis
13.7.6 Key Strategy
13.8 Terumo Corporation
13.8.1 Company Overview
13.8.2 Financial Overview
13.8.3 Products Offering
13.8.4 Key Developments
13.8.5 SWOT Analysis
13.8.6 Key Strategy
13.9 Natus Medical Incorporated
13.9.1 Company Overview
13.9.2 Financial Overview
13.9.3 Products Offering
13.9.4 Key Developments
13.9.5 SWOT Analysis
13.9.6 Key Strategy
13.1 Johnson & Johnson Services Inc.
13.10.1 Company Overview
13.10.2 Financial Overview
13.10.3 Products Offering
13.10.4 Key Developments
13.10.5 SWOT Analysis
13.10.6 Key Strategy
13.11 B. Braun Melsungen AG
13.11.1 Company Overview
13.11.2 Financial Overview
13.11.3 1.10.3 Products Offering
13.11.4 Key Developments
13.11.5 SWOT Analysis
13.11.6 1.10.6 Key Strategy
13.12 Christoph Miethke GmbH & Co. KG
13.12.1 Company Overview
13.12.2 Financial Overview
13.12.3 Products Offering
13.12.4 Key Developments
13.12.5 SWOT Analysis
13.12.6 Key Strategy
13.13 Tokibo Co., Ltd.
13.13.1 Company Overview
13.13.2 Financial Overview
13.13.3 Products Offering
13.13.4 Key Developments
13.13.5 SWOT Analysis
13.13.6 Key Strategy
13.14 HLL Lifecare Limited
13.14.1 Company Overview
13.14.2 Financial Overview
13.14.3 Products Offering
13.14.4 Key Developments
13.14.5 SWOT Analysis
13.14.6 Key Strategy
14 Appendix
14.1 Discussion Blue Print